Our data further suggest that early intervention via disease-modifying therapies or lifestyle-based modifications in AD could result in cost savings for society. Additionally, our findings reinforce the importance of accounting for the full value of innovative interventions, management and care paradigms, including their potential impact on direct, indirect and intangible costs impacting patients, their care partners and health and social care systems.
Keyphrases
- healthcare
- palliative care
- quality improvement
- end stage renal disease
- mental health
- randomized controlled trial
- public health
- ejection fraction
- physical activity
- newly diagnosed
- chronic kidney disease
- metabolic syndrome
- cardiovascular disease
- weight loss
- type diabetes
- machine learning
- human health
- artificial intelligence
- human immunodeficiency virus
- hiv infected
- hiv testing